Skip to Content

Celvapan

Active Substance: whole virion, inactivated containing antigen: A/California/07/2009 (H1N1)v
Common Name: influenza vaccine (H1N1)v (whole virion, inactivated, prepared in cell culture)
ATC Code: J07BB01
Marketing Authorisation Holder: Nanotherapeutics Bohumil, s.r.o.
Active Substance: whole virion, inactivated containing antigen: A/California/07/2009 (H1N1)v
Status: Withdrawn
Authorisation Date: 2009-03-04
Therapeutic Area: Influenza, Human Disease Outbreaks Immunization
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

Prophylaxis of influenza caused by A(H1N1)v 2009 virus.

Celvapan should be used in accordance with official guidance.

The marketing authorisation for Celvapan has been withdrawn at the request of the marketing-authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide